logo

NRIX

Nurix Therapeutics·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --

NRIX fundamentals

Nurix Therapeutics (NRIX) released its earnings on Jul 9, 2025: revenue was 44.06M (YoY +264.37%), beat estimates; EPS was -0.52 (YoY +26.76%), beat estimates.
Revenue / YoY
44.06M
+264.37%
EPS / YoY
-0.52
+26.76%
Report date
Jul 9, 2025
Earnings Call
4:00 PM on Jul 7, 2025
Meeting link.
EPS
Revenue

Revenue & Expenses

NRIX has released its 2025 Q3 earnings report, with revenue of 7.89M, reflecting a YoY change of -37.29%, and net profit of -86.42M, showing a YoY change of -76.53%. The Sankey diagram below clearly presents NRIX's revenue sources and cost distribution.

Key Indicators

Nurix Therapeutics (NRIX) key financial stats and ratios, covering profitability, financial health, and leverage.
Nurix Therapeutics (NRIX)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Nurix Therapeutics (NRIX)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Nurix Therapeutics (NRIX)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Nurix Therapeutics (NRIX) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Nurix Therapeutics (NRIX) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield